Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIIB single-arm trial of prophylactic emicizumab in hemophilia A patients with inhibitors
2016-004366-25Phase 3Completed
- Sponsor
- Roche
- Start
- Jun 2017
- Modality
- Bispecific Antibodies → Multispecific Antibodies → Engineered Antibody Formats → Antibody-Based Therapeutics, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of emicizumab in hemophilia A, sponsored by Roche. Started Jun 2017; status: completed.
02
Drugs
emicizumab
03
Conditions
hemophilia A
Beyond the preview
Go deeper on 2016-004366-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004366-25.